Patient Outcomes after Cardiac Surgery for Carcinoid Heart Disease Are Dependant Upon Successful Cytoreductive Multimodal Treatment and Control of Metastatic Neuroendocrine Disease
#1818
Introduction: Carcinoid Heart Disease (CHD) as a result of long standing carcinoid syndrome is associated with a poor prognosis due to development of valvular incompetence & right heart failure. Cardiac valve surgery is the main therapeutic option.
Aim(s): To assess the long term outcomes of patient undergoing valve surgery as part of a multimodal cytoreductive treatment strategy for metastatic NET.
Materials and methods: Review of patients presenting to the regional NET multidisciplinary meeting over a 5-year period who underwent valve surgery for CHD.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Jaber B, Ramsey E, Cowburn P, Tsang G, Armstrong T,
Keywords: Carcinoid heart disease, surgery,
To read the full abstract, please log into your ENETS Member account.